虾和蟹组织中CAP检测方法.docx
《虾和蟹组织中CAP检测方法.docx》由会员分享,可在线阅读,更多相关《虾和蟹组织中CAP检测方法.docx(19页珍藏版)》请在冰豆网上搜索。
虾和蟹组织中CAP检测方法
DeterminationofChloramphenicolResiduesinShrimpandCrabTissuesbyElectrosprayTripleQuadrupoleLC/MS/MS
JoeStorey,AlPfenning,SherriTurnipseed,GeneNandrea,RebeccaLee,CathyBurns,MarkMadson
DenverDistrictLaboratoryand
AnimalDrugsResearchCenter
FoodandDrugAdministration
P.O.Box25087,DenverCO80225-0087
Abstract:
ThisLIBdescribesasolidphaseextractionandcleanupprocedureforthedeterminationofchloramphenicolresiduesinshrimpandcrab.Chloramphenicolisdetected,afterchromatographicseparation,usingaThermoElectronTSQQuantumtriplequadrupolemassspectrometerwithanESIsourceoperatinginnegativeionmode.Aninternalstandardisusedtocorrectforvariabilityofextractionandinstrumentresponse.Fourproductionsofchloramphenicolandoneproductionoftheinternalstandardaremonitoredusingselectedreactionmonitoring(SRM).Chloramphenicolcanbequantitatedandconfirmedatthe0.1ppblevel.
TheLaboratoryInformationBulletinisatoolfortherapiddisseminationoflaboratorymethods(orinformation)whichappeartowork.Itmaynotreportcompletedscientificwork.Theusermustassurehim/herselfbyappropriatevalidationproceduresthatLIBmethodsandtechniquesarereliableandaccurateforhis/herintendeduse.Referencetoanycommercialmaterials,equipment,orprocessdoesnotinanywayconstituteapproval,endorsement,orrecommendationbytheFoodandDrugAdministration.
Introduction
Recentlyithasbeenreportedthattheantibioticchloramphenicol(CAP)hasbeenfoundinseveralimportedfoodstuffsfromAsia,includingshrimp,crabandcrayfish.Initially,severalconfirmatoryanalyticalLC/MS/MSmethodsforchloramphenicolusingiontrapdetectionweredevelopedbytheDenverDistrictAnimalDrugsResearchCenter(ADRC)ofFDAtoaddressthisproblem.Specifically,LIBs4284,4287,4294,4281(1-4)describemethodsdevelopedtoqualitativelyconfirmCAPinshrimp,crayfish,crab,andhoney,respectively,at1ppborhigher.Usingthesemethodsoverthelastyear,severalFDAlaboratorieshavepositivelyconfirmedthepresenceofCAPinmanyimportsamplesoftheaforementionedfoods.Thesemethodsemploynegativeionmodewithelectrosprayionization.InthesemethodsfullscanMS2spectrawereobtainednotonlyfromtheparentCAPion(m/z=321),butalsofromthecorrespondingm/z=323ionM+2(35Cl,37Cl)isotope.Theiontrapfullscandatagaveexcellentpositiveidentificationbutwasnotquiteassuccessfulforprecisequantitationorsensitiveenoughtodetectsub-ppbCAPlevels.ItwasrequestedthatamoresensitiveconfirmatorymethodforCAPbedevelopedforuseinthefield.
Togainthisaddedsensitivity,typicallyatriplequadrupoleLC/MS/MSoperatinginSelectedReactionMonitoringorSRMmodeisused.InSRM,insteadofmonitoringtheentiremassspectrumoftheproductionsofaparention,onlyafewselectedproductionsaremonitored.SeattleDistrictLaboratoryhasrecentlydevelopedatriplequadrupoleFinniganTSQ7000LC/MS/MSmethod(5)fortheanalysisofCAPinshrimp(LIB4290)whichseemstoworkwellwithaLOQof0.3ppbandaLODof0.08ppb.However,ournewermodeltriplequadrupoleinstrument(aTSQQuantum,alsousingnegativeionmodeESILC/MS/MS)gaveappreciabledownwarddriftinresponsetochloramphenicolaftermanyinjectionsduringarunsequence,possiblyduetoionsuppression.AnotherFDAlaboratory(verbalcommunication)hasalsoexperiencedasimilareffectoperatinginnegativeionmode.ForthisreasonwewouldnotbeabletousetheSeattlemethodwithoutaninternalstandard.
ThisLIBdescribesanadditionalmethodfortheLC/MS/MSdetectionofchloramphenicolinshrimpandcrab.DifferencesbetweenourmethodandtheSeattlemethodinclude:
1)Aninternalstandard(IS),meta-Chloramphenicolorm-CAP,isaddedatthebeginningoftheextractioninourmethod.Theuseofaninternalstandardself-correctsforanyextractionvariabilityfromsampletosampleandshouldalsoself-correctforanydriftindetectorresponseduringarun.WiththeuseofanIS,0.1ppbCAPlevelsintissuecanbereliablyquantitated.
2)Theextractionemployedinourmethoddoesnotuseseparatoryfunnelsbutusesdisposableglasswaretominimizethepossibilityofcross-contamination.
3)AmobilephaseofonlyacetonitrileandwaterwithoutanysaltbuffersisusedinourmethodwhichshouldhelpminimizeMSmaintenance.
Overviewofmethod
TheextractionusedinthemethoddescribedinthisLIBisasimplifiedversionofthatdescribedinLIB4284.Tengramsoftissuecomposite(withaddedm-CAPinternalstandard)isextracted(3x)inammoniatedethylacetate.Thecombinedextractsareevaporatedandre-dissolvedinwater.Ahexanewashremovesfats.Theextractisthenappliedtoareverse-phaseSPEcolumnandtheCAPiselutedwithmethanol.Themethanolisevaporatedtodrynessandtheextractisreconstitutedinwater,filteredandinjectedintotheLC/MSforanalysis.Them/z321[M-H]ionforbothCAPandtheinternalstandardm-CAPisisolatedinQ1,withfiveproductionsisolatedinQ3.ConfirmationofCAPismadebycomparisonofionchromatogrampeakswiththoseofaCAPstandard.QuantitationofCAPismadebytakingtheratiooftheCAPbasepeakarea(m/z152)totheinternalstandardm-CAPbasepeakarea(m/z207).ThisMSapproachisanadaptation(asperamanuscriptkindlyprovidedtoDenverLaboratorybyFDA’sCenterforVeterinaryMedicine)ofaCanadianmethod(6).TheCanadianmethod’sHPLCcolumnwithamodifiedmobilephaseisusedinthisLIB.Alsowefoundthatbyaddingtheinternalstandardm-CAPatthebeginningoftheextractioninsteadofattheendincreasedthereproducibilityofthemethod.Finally,wealsousedahigherlevelofinternalstandard(0.3ppb)togiveamoreintenseresponse.
InternalStandardpreparation:
(fortificationsolutionpreparationisinitalics).
Theinternalstandardusedism-chloramphenicol(m-CAP),wascustomsynthesizedfortheFDA.
1.A100µg/mLstockstandardm-CAPsolutioninacetonitrile(acn)isprepared.
2.A1:
100dilutioninacnofthestockstandardgivesanintermediatestandardconcentrationof1µg/mLor1000ng/mLm-CAP.
3.ThreemLoftheintermediatestandardisdilutedto500mLwithwatertogiveam-CAPconcentrationof6ng/mLdiluentsolution(ThisdiluentsolutionisusedtopreparetheLC/MSstandards).
4.FivemLoftheintermediatestandardisdilutedto250mLwithwatertogivethem-CAPfortificationsolutionof20ng/mL.Every10.0gsampleisfortifiedwith150µLofm-CAPfortificationsolutionfora0.3ppbIS(internalstandard)concentration—thisisequivalenttoa6ng/mLfinalvialconcentrationofm-CAP.
Chloramphenicolstdpreparation:
(preparationoffortificationsolutionsinitalics).
ChloramphenicolstandardusedisthecurrentUSPlot.
1.A100µg/mLstockstandardCAPsolutioninacetonitrile(acn)isprepared.
2.A1:
100dilutionwithm-CAPdiluentofthestockstandardgivesanintermediatestandardconcentrationof1µg/mLor1000ng/mLCAP.
3.A1:
10dilutionoftheintermediateCAPstandardwithm-CAPdiluentgivesa100ng/mLCAPconcentrationstandardequivalenttoa5ppbCAPstandard.
4.A6:
10and4:
10dilutionofthe5ppbCAPstandardwithm-capdiluentgives3ppband2ppbstandardsrespectively.A5.00mLto25.00mLdilutionwithm-capdiluentgivesa1ppbCAPstandard.
5.A6.00,3.00,1.00,and0.00mLdilutionofthe1ppbCAPstandardto10.00mLwithm-CAPdiluentgives0.6,0.3,0.1,and0ppbCAPstandardsrespectively.The1.0,0.6,0.3and0.1ppbCAPstandardswillhaveCAPconcentrationsof20,12,6,and2ng/mLrespectively.The0.3ppbstandardcanbeusedastheCCVsolution.Asimilar,butpreparedwithadifferentCAPstocksolution,0.1ppbICVCAPstandard(butusingthesamediluentsolution)isalsoprepared.
6.PreparationofCAPfortificationsolutions.(Thesesolutionsdonothavem-capdiluentinthembutaredilutedwithwater).Usingthe100ug/mLCAPstocksolutionabovea1:
100dilutionismadewithwater;1.00mLofthissolutionisdilutedto10mLwithwatertogiveCAPfortificationsolution#1of100ng/mLconcentration.A2:
10dilutionoffortificationsolution#1givesfortificationsolution#2of20ngCAP/mLinwater.For10.0gtissue,preparea0.1ppbspikebyadding50µLoffortificationsolution#2.Preparea0.3ppbspikebyadding30uLoffortificationsolution#1.Preparea0.6ppbspikebyadding60µLoffortificationsolution#1andsoon.
Samplepreparation
1.Placepeeled(ifapplicable)tissueinblender,andblendwithdryiceusingrobotcoupemixerwithpulsedactionuntilcontentsareuniform(7).
2.Accuratelyweigh(tothenearesttenthofagram)10.0gofblendedmeatcompositeintoa50mLpolypropylene(P/P)centrifugetube.Fortifyasdescribedinthestandardpreparationsection.
3.Add20mLofextractionsolution(EtOAC:
NH4OH,98:
2)homogenizewithvortexeruntiltheentiremassisbrokenup(about30sec).MixonpulsedMultitubeVortexerfor10minutes.
4.Centrifugefor7min@4000rpm,decantintoanother50mLpolypropylenecentrifugetubeandplaceinN-Evapsetat50oCtobeginevaporationundernitrogen.
5.Repeatextractionsteps3and4twomoretimes,combiningtheextracts.
6.Finishevaporatingtodrynessundernitrogen.
7.Add30mLof0.05%aceticacidinH2Otodriedextract,vortexca.1mintoloosenresiduethencontinuetovortexaminimumof5min.
8.Add10mLofhexanetothe50mLtube,andcap.Inverttubegentlyseveraltimessothatemulsionsdonotformbutensureanysolidsaredissolved,centrifuge3minat4000rpm.Aspiratewithdisposablepipetteanddiscardhexanelayer.Repeathexanede-fattingsteptwicemorewithtwoadditional5mLportionsofhexanea